Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique

Journal of the Formosan Medical Association

Volumn 105, Issue 9, 2006, Pages 695-700

  Jan, I Shiow ^a   Chung, Ping Fung ^a   Weng, Ming Hsiang ^a   Huang, Min Se ^a   Lee, Ya Ting ^a   Kuo, Sow Hsong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Body fluid; Cytology; Immunocytochemistry; Thyroid transcription factor 1

Indexed keywords

THYROID TRANSCRIPTION FACTOR 1;

ARTICLE; BODY FLUID; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CELL TRANSFER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MEDICAL RECORD REVIEW; METASTASIS POTENTIAL; OVARY CARCINOMA; PAPANICOLAOU TEST; PLEURA CAVITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; STOMACH CARCINOMA; TARGET CELL;

EID: 33749350850     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60196-0     Document Type: Article

References (32)

1. Smith GP, Kjeldsberg CR. Cerebrospinal, synovial, and serous body fluids. In: Henry JB ed. Clinical Diagnosis and Management by Laboratory Methods, 20th edition. Philadelphia: Saunders, 2001:403-24.
2. DiBonito L, Falconieri G, Colautti I, et al. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1993; 37:483-8.
3. DiBonito L, Falconieri G, Colautti I, et al. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1992; 36:329-32.
4. Lazzaro D, Price M, de Felice M, et al. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093-104.
5. Bingle CD. Thyroid transcription factor-1. Int J Biochem Cell Biol 1997;29:1471-3.
6. Kelly SE, Bachurski CJ, Burnhans MS, et al. Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor-1. J Biol Chem 1996;271: 6881-8.
7. Holzinger A, Dingle S, Bejarano PA, et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 1996;15:49-53.
8. Comperat E, Zhang F, Perrotin C, et al. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod Pathol 2005; 18:1371-6.
9. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol 2003;34:597-604.
10. Stenhouse G, Fyfe N, King G, et al. Thyroid transcription factor 1 in pulmonary adenocarcinoma. J Clin Pathol 2004; 57:383-7.
11. Saad RS, Liu YL, Han H, et al. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Hum Pathol 2004;35:3-7.
12. Chang YL, Lee YC, Liao WY, et al. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 2004;44: 149-57.
13. Romeike BF, Feiden W. Diagnostic value of the monoclonal antibody to thyroid transcription factor-1 (TTF-1) in CNS metastases. An immunohistochemical study of 65 cases. Pathologe 2002;23:292-6. [In German]
14. Srodon M, Westra WH. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Hum Pathol 2002;33:642-5.
15. Bohinski RJ, Bejarano PA, Balko G, et al. Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1. J Neurooncol 1998;40:227-31.
16. Roh MS, Hong SH. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes. J Korean Med Sci 2002;17:512-7.
17. Gomez-Fernandez C, Jorda M, Delgado PI, et al. Thyroid transcription factor 1: a marker for lung adenocarcinoma in body cavity fluids. Cancer 2002;96:289-93.
18. Afify AM, al-Khafaji BM. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Acta Cytol 2002;46:675-8.
19. Ng WK, Chow JC, Ng PK. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens. Cancer 2002;96:43-8.
20. Jang KY, Kang MJ, Lee DG, et al. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Anal Quant Cytol Histol 2001;23:400-4.
21. Hecht JL, Pinkus JL, Weinstein LJ, et al. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 2001;116:483-8.
22. Harlamert HA, Mira J, Bejarano PA, et al. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Acta Cytol 1998;42:1382-8.
23. Khoor A, Whitsett JA, Stahlman MT, et al. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 1999;30:695-700.
24. Byrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 2000;31: 58-62.
25. Cheuk W, Kwan MY, Suster S, et al. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 2001;125: 228-31.
26. Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors - a comparison of direct smears and cell block preparations. Cancer 2004;102:109-14.
27. Chhieng DC, Cangiarella JF, Zakowski MF, et al. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 2001;93:330-6.
28. Gong Y, Joseph T, Sneige N. Validation of commonly used immunostains on cell-transferred cytologic specimens. Cancer 2005;105:158-64.
29. Brown GG, Tao LC. Restoration of broken cytology slides and creation of multiple slides from a single smear preparation. Acta Cytol 1992;36:259-63.
30. Sherman ME, Jimenez-Joseph D, Gangi MD, et al. Immunostaining of small cytologic specimens facilitation with cell transfer. Acta Cytol 1994;38:18-22.
31. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
32. Elston RC, Johnson WD. Essentials of Biostatistics, 2nd edition. Philadelphia: Davis, 1994:34-63.